NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP
Tactile Systems Technology Inc. TCMD
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$329.5M
▲ 12.5% vs FY2024
EPS · FY25
$0.82
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
8.8%
Net margin · FY25
5.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 329.5M
Revenue, FY2025 · full 12-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 0.82
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
8.8%
Return on equity, FY2025
ROE
Operating margin8.9%
Net margin5.8%
Return on assets6.7%
Each USD of equity produced 9 cents of profit this year.
Returned to shareholders
USD 26.3M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 26.3M
Share of profit138.0%
Consecutive raises—
USD 26.3M in buybacks — 138% of the year's profit, so the payout drew on cash built up earlier.
Growth
+12.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.1%
+12.0%
+18.0%
Net income
+29.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.02B
Shares outstanding, FY2025
Change, 5 years+15.1%
Change, 10 years—
The share count grew 15% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 273.9M
total assets, end of FY2025
Total assetsUSD 273.9M
EquityUSD 218.9M
CashUSD 83.4M
Gross debtUSD 0.00
Net debtUSD -83.4M
Current ratio4.03×
The company holds more cash than debt.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue $B
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
Operating income $B
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
−0.0
0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
0.82
0.70
1.23
−0.89
−0.60
−0.03
0.56
0.34
0.31
0.15
−0.15
0.02
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
8.8
8.3
18.1
−14.3
−9.3
−0.5
10.9
8.2
8.8
10.7
·
·
Shares out B
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
46 of 46
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed